Larson I - Search Results

1

Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.

Dong YD, Larson I, Hanley T, Boyd BJ. Dong YD, et al. Among authors: larson i. Langmuir. 2006 Nov 7;22(23):9512-8. doi: 10.1021/la061706v. Langmuir. 2006. PMID: 17073473

2

Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications.

Dong YD, Larson I, Barnes TJ, Prestidge CA, Allen S, Chen X, Roberts CJ, Boyd BJ. Dong YD, et al. Among authors: larson i. Langmuir. 2012 Sep 18;28(37):13485-95. doi: 10.1021/la302435g. Epub 2012 Aug 31. Langmuir. 2012. PMID: 22889049

3

Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.

Dong YD, Dong AW, Larson I, Rappolt M, Amenitsch H, Hanley T, Boyd BJ. Dong YD, et al. Among authors: larson i. Langmuir. 2008 Jun 1;24(13):6998-7003. doi: 10.1021/la8005579. Epub 2008 Jun 4. Langmuir. 2008. PMID: 18522450

4

Nonequilibrium effects in self-assembled mesophase materials: unexpected supercooling effects for cubosomes and hexosomes.

Dong YD, Tilley AJ, Larson I, Lawrence MJ, Amenitsch H, Rappolt M, Hanley T, Boyd BJ. Dong YD, et al. Among authors: larson i. Langmuir. 2010 Jun 1;26(11):9000-10. doi: 10.1021/la904803c. Langmuir. 2010. PMID: 20364857

5

Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.

Nguyen TH, Hanley T, Porter CJ, Larson I, Boyd BJ. Nguyen TH, et al. Among authors: larson i. J Pharm Pharmacol. 2010 Jul;62(7):844-55. doi: 10.1211/jpp.62.06.0005. J Pharm Pharmacol. 2010. PMID: 20636872

6

Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.

Nguyen TH, Hanley T, Porter CJ, Larson I, Boyd BJ. Nguyen TH, et al. Among authors: larson i. J Pharm Pharmacol. 2010 Jul;62(7):856-65. doi: 10.1211/jpp.62.06.0006. J Pharm Pharmacol. 2010. PMID: 20636873

7

Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds.

Dong YD, Larson I, Barnes TJ, Prestidge CA, Boyd BJ. Dong YD, et al. Among authors: larson i. ACS Appl Mater Interfaces. 2011 May;3(5):1771-80. doi: 10.1021/am2003069. Epub 2011 May 9. ACS Appl Mater Interfaces. 2011. PMID: 21506614

8

Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases.

Jin L, Zhou QT, Chan HK, Larson IC, Pennington MW, Morales RAV, Boyd BJ, Norton RS, Nicolazzo JA. Jin L, et al. J Pharm Sci. 2016 Feb;105(2):650-656. doi: 10.1016/j.xphs.2015.10.025. Epub 2016 Jan 12. J Pharm Sci. 2016. PMID: 26869426

9

Enabling Noninvasive Systemic Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] via the Buccal Mucosa.

Jin L, Boyd BJ, Larson IC, Pennington MW, Norton RS, Nicolazzo JA. Jin L, et al. J Pharm Sci. 2016 Jul;105(7):2173-9. doi: 10.1016/j.xphs.2016.05.008. Epub 2016 Jun 13. J Pharm Sci. 2016. PMID: 27312508

10

Determination of the polar and total surface energy distributions of particulates by inverse gas chromatography.

Das SC, Larson I, Morton DA, Stewart PJ. Das SC, et al. Among authors: larson i. Langmuir. 2011 Jan 18;27(2):521-3. doi: 10.1021/la104135z. Epub 2010 Dec 21. Langmuir. 2011. PMID: 21174410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters